How the U.S. Can Immunize Americans With Multiple Vaccines

Bloomberg Quicktake: Now published this video item, entitled “How the U.S. Can Immunize Americans With Multiple Vaccines” – below is their description.

Moderna’s vaccine was deemed safe by U.S. regulators, clearing the way for a second shot to quickly gain emergency use authorization.

Bloomberg Quicktake: Now YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

About This Source - Bloomberg QuickTake: Now

Bloomberg L.P. is a privately held financial, software, data, and media company headquartered in Midtown Manhattan, New York City.

It was founded by Michael Bloomberg in 1981, with the help of Thomas Secunda, Duncan MacMillan, Charles Zegar, and a 12% ownership investment by Merrill Lynch.

Recent from Bloomberg QuickTake: Now:

  • German Election: Narrow Victory for Social Democrats Leaves Country in Limbo
  • Protests In Tunisia Continue Amid Political Crisis
  • Mourners Attend Gabby Petito’s Memorial Service
  • In This Story: Moderna

    Moderna is an American biotechnology company based in Cambridge, Massachusetts that focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA.

    CEO: Stéphane Bancel (2011–)

    Stock ticker: (NASDAQ:MRNA)

    5 Recent Items: Moderna

  • Canadians try pronouncing the new COVID-19 vaccines names
  • Final Trades: Moderna, Palo Alto Networks, Umpqua Holdings & more
  • Melbourne construction worker’s desperate message after COVID mistake | 7NEWS
  • Young Canberrans lining up for their first Moderna vaccine, open for 12 to 59-year-olds | ABC News
  • What’s fueling the world’s Covid-19 vaccination disparity? | Inside Story
  • Leave a Comment

    We don't require your email address now, just your name. BUT, if you do add it, you may be notified if there are replies to your comment. Please make respectful comments, which add value, and avoid personal attacks on others. Comments failing to adhere to these guidelines will not be published.